Quick Facts
- • RDA: 310-420mg/day (varies by sex/age)
- • Common deficiency: 48% of US adults below EAR
- • Best forms for cognition: L-threonate (crosses BBB)
- • Best form for sleep: glycinate (dual mechanism with glycine)
- • Avoid oxide: ~4% bioavailability, primarily laxative
Magnesium is an essential mineral and cofactor in over 300 enzymatic reactions, including ATP production, DNA synthesis, neurotransmitter regulation, and vascular tone. It exists in the body predominantly inside cells and bone; serum magnesium represents less than 1% of total body stores and is therefore a poor marker of status except in severe deficiency. Red blood cell (RBC) magnesium provides a more reliable intracellular estimate.
Supplementation evidence is strongest for specific forms matched to specific indications. Magnesium glycinate (also labeled bisglycinate) combines magnesium with the calming amino acid glycine and has the best-documented effects for sleep quality and anxiety, typically at 300-400mg elemental daily taken evening. Magnesium L-threonate is the only form demonstrated to cross the blood-brain barrier and elevate cerebrospinal fluid magnesium in humans, making it preferred for cognitive indications at 1,500-2,000mg daily (delivering approximately 144mg elemental). Magnesium citrate is well-absorbed but causes loose stools at higher doses. Magnesium oxide should be avoided for most indications due to bioavailability near 4%.
Clinically relevant deficiency contributes to migraine frequency, muscle cramps, poor sleep architecture, premenstrual symptoms, and elevated blood pressure. Populations at elevated risk include adults on proton pump inhibitors, diuretics, or metformin; individuals with Crohn’s disease or celiac disease; and heavy alcohol users. Supplementation is generally safe up to 350mg daily from supplements in adults without renal impairment, though higher doses (used in specific protocols) require slow titration to avoid gastrointestinal effects.
Adults with ADHD show consistent deficits in iron (ferritin <30 ng/mL in 84%), vitamin D (6.5 ng/mL lower), zinc, and magnesium. Supplementing these deficiencies produces measurable symptom improvements — particularly ferritin optimization (target >50 ng/mL), vitamin D (4000 IU/day), and zinc (15–30mg). L-tyrosine shows no benefit and develops tolerance. Screen for deficiencies before supplementing; prioritize iron and vitamin D testing.
28 sources 3/4 moderate Updated 2026-04-15
A seven-compound nutraceutical protocol (Omega-3 EPA ≥60%, Saffron 30mg, SAM-e, L-Methylfolate, Zinc, Curcumin+piperine, Magnesium glycinate) has demonstrated adjunctive efficacy for anxiety and depression across multiple RCTs and meta-analyses. Omega-3 EPA (≥1g/day) reduces depressive symptoms with effect size d≈0.61 in meta-analysis; Saffron 30mg/day matches fluoxetine 20mg in multiple head-to-head RCTs (n=40–60 per study). SAM-e (800–1600mg) and L-Methylfolate (15mg) show strong evidence specifically as SSRI augmentation. This protocol is intended as an adjunct to, not replacement for, standard psychiatric care.
22 sources 4/4 strong Updated 2026-04-15
Evidence-based cognitive enhancement is achievable without high-risk compounds. The safety-first stack prioritizes compounds with ≥2 human RCTs, no significant dependency risk, and well-characterized safety profiles: L-Theanine + caffeine (gold standard for acute focus), Bacopa monnieri (12-week memory consolidation), Magnesium L-Threonate (sleep and synaptic plasticity), and Rhodiola rosea (anti-fatigue). Alpha-GPC and Citicoline are effective cholinergic precursors, with Citicoline preferred if TMAO concerns are relevant. NACET shows promise but lacks sufficient direct human RCT evidence to fully recommend — NAC's established evidence partially supports its use.
18 sources 3/4 moderate Updated 2026-04-15
Natural interventions for attention and focus show modest but real effects — especially for non-diagnosed 'brain fog' and subclinical attention difficulties. For clinically diagnosed ADHD, medication (stimulants or atomoxetine) remains the gold standard with the strongest evidence; natural compounds are best used as adjuncts or in cases where medication is declined. The strongest-evidenced natural interventions are: Magnesium (especially in those who are deficient), L-Theanine + low-dose caffeine (best acute focus combo), Omega-3 fatty acids EPA-dominant (particularly in children), and NAC for impulsivity. Effect sizes are consistently smaller than pharmaceutical interventions.
10 sources 3/4 moderate Updated 2026-04-15
For women unwilling or unable to use HRT, a targeted nutraceutical stack — anchored by magnesium bisglycinate, omega-3 fatty acids, and vitamin D3+K2 — offers moderate evidence for reducing vasomotor symptoms, improving sleep quality, and stabilizing mood during the menopausal transition. Maca (Lepidium meyenii) shows promising evidence for FSH/LH modulation and hot flash reduction, particularly in early postmenopausal women. DIM (diindolylmethane) may support favorable estrogen metabolism ratios but direct symptom evidence remains limited; it requires caution in women with estrogen-sensitive conditions. No supplement replaces HRT for severe vasomotor symptoms — be honest about that limit.
16 sources 3/4 moderate Updated 2026-04-15
Postpartum depletion is near-universal: >50% of women enter the postpartum period iron-deficient, with ferritin commonly <30 μg/L; optimal target is >50 μg/L for symptom resolution. Vitamin D deficiency affects 40–80% of new mothers and requires 2000–4000 IU/day for repletion. DHA depletion at delivery averages 48–50% vs. pre-pregnancy levels and directly correlates with mood and cognitive performance. A phased 6–12 month protocol combining iron + D3/K2 + magnesium glycinate + B12/methylfolate + omega-3 DHA/EPA resolves the majority of postpartum fatigue, brain fog, and telogen effluvium within 3–6 months.
18 sources 4/4 strong Updated 2026-04-15
The strongest evidence-based sleep supplement stack centers on four compounds: Magnesium glycinate (300–400 mg, 60–90 min before bed) modulates GABA and lowers cortisol for deeper NREM; Glycine (3 g, 30–60 min before bed) reduces core body temperature via NMDA receptors in the SCN, shortening sleep latency and improving slow-wave sleep; L-Theanine (100–200 mg, 30–60 min before bed) induces alpha-wave activity for calm, non-sedating relaxation; and low-dose Melatonin (0.3–0.5 mg, 90–120 min before bed) resets circadian timing without grogginess. Apigenin (50 mg from chamomile extract) is a reasonable addition for anxiolytic GABA-A modulation, though most RCT evidence is for chamomile extract rather than isolated apigenin. Use this stack for sleep onset + deep sleep quality; morning refresh comes primarily from consistent sleep timing and avoiding high-dose melatonin.
12 sources 4/4 strong Updated 2026-04-15
Burnout and chronic stress are distinct from acute stress and require fundamentally different interventions — adaptogens modulate HPA axis dysregulation rather than simply suppressing it. The strongest human evidence supports Ashwagandha KSM-66 (cortisol ↓27.9% in 8-week RCT, n=272) and Rhodiola SHR-5 extract (only adaptogen with a dedicated burnout RCT showing fatigue reversal). Timing matters critically: Rhodiola in the morning for HPA normalization, Ashwagandha and Magnesium in the evening for cortisol lowering. Supplements are supportive — lifestyle (sleep, exercise timing, nature exposure) is the primary intervention; without it, adaptogens provide marginal benefit.
15 sources 3/4 moderate Updated 2026-04-15
Systematic supplementation targeting nutrient deficiencies can significantly reduce PPD risk. Key interventions: omega-3 (EPA-dominant, 2-3g/day), ferritin optimization (>50 μg/L), vitamin D (4000-6000 IU), magnesium glycinate (300-600mg), and L. rhamnosus HN001 probiotic. A three-phase protocol (prenatal → critical postpartum → extended) addresses the neurobiological cascade triggered by postpartum hormone collapse.
47 sources 4/4 strong Updated 2026-04-13